Lane, J., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahão, M., Alghoul, H., Alser, O., Alshammari, T., Biedermann, P., Banda, J., Burn, E., Casajust, P., Conover, M., Culhane, A., Davydov, A., DuVall, S., Dymshyts, D., Fernández-Bertolín, S., Fišter, K., Hardin, J., Hester, L., Hripcsak, G., Kaas-Hansen, B., Kent, S., Khosla, S., Kolovos, S., Lambert, C., van der Lei, J., Lynch, K., Makadia, R., Margulis, A., Matheny, M., Mehta, P., Morales, D., Morgan-Stewart, H., Mosseveld, M., Newby, D., Nyberg, F., Ostropolets, A., Park, R., Prats-Uribe, A., Rao, G., Reich, C., Reps, J., Rijnbeek, P., Sathappan, S., Schuemie, M., Seager, S., Sena, A., Shoaibi, A., Spotnitz, M., Suchard, M., Torre, C., Vizcaya, D., Wen, H., de Wilde, M., Xie, J., You, S., Zhang, L., Zhuk, O., Ryan, P. & Prieto-Alhambra, D. 2020, 'Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study', The Lancet Rheumatology, 2(11), pp. E698-E711. https://doi.org/10.1016/S2665-9913(20)30276-9